Year: 2009
Type: article
Abstract: Research on pediatric anxiety disorders illustrates particularly exciting themes emerging in the conceptualization of mental illness pathophysiology. This excitement reflects the unique opportunities for preventative and therapeutic advances that can evolve in the context of an integrative perspective, which incorporates themes in developmental and neuroscience research. This overview is grounded in a translational perspective that views adult mood and anxiety disorders as developmental conditions. Central to this perspective is the fact that an evolutionarily conserved neural architecture allows mammals to learn about dangers and that plasticity plays a profound role in this learning process, by shaping individual differences in functional aspects of this architecture. These concepts are supported by translational neuroscience studies that link research on individual differences in mammalian fear-circuitry function to risks for and manifestations of psychopathology, with a particular emphasis on findings in youths. Finally, this integrative perspective uniquely informs prevention and treatment. In this overview, I will use this perspective to illustrate the specific opportunities for mood and anxiety disorder prevention and treatment. However, a similar integrative perspective may shape approaches to diverse mental illnesses. Pediatric anxiety disorders represent precursors for diverse, potentially chronic mental illnesses, including both adult mood and anxiety disorders. Longitudinal research, based in community, family-based, and clinical settings, links various anxiety disorders to a diverse array of outcomes, including adult mood and anxiety disorders.1, 2 Two major sets of questions arise from this work. The first set of questions relates to observations of both specificity and nonspecificity in outcomes. While pediatric anxiety disorders are more likely to increase risk for adult anxiety disorders than adult behavior disorders, such as antisocial personality disorder, specific pediatric anxiety disorders actually predict an equally high degree of increased risk for diverse adult mood and anxiety disorders.1, 3 Moreover, the association between the level of pediatric anxiety and the degree of risk for adverse outcomes appears linear, without a clear separation between the risk associated with clinical as opposed to subclinical anxiety states.4 Thus, both subclinical and clinical anxiety as well as temperamental variations in anxiety place children at risk.1, 5 Taken together, work on specificity and nonspecificity in outcomes suggests that current nosology captures some aspects of perturbed emotional experience unique to mood and anxiety disorders but fails to capture the core pathophysiology of sharply dissociable clinical anxiety states. Research on neuroscience holds the hope of addressing questions in this area. The second set of questions relates to the nature of longitudinal trajectories. Anxiety disorders are extremely common in young people, with approximately one-third of children and adolescents manifesting clinically significant anxiety at some point in development.5 Most of these anxiety states resolve. However, among adults afflicted with various mood and anxiety disorders, the majority had suffered from an anxiety disorder during development; an even higher proportion manifested clinical anxiety, a subclinical condition, or a temperament that placed them at risk.5 Thus, while most pediatric anxiety states are transient, the majority of adult mood and anxiety disorders arise from the minority of pediatric anxiety states that persist. As such, longitudinal work suggests that the key to understanding mood and anxiety disorder pathophysiology across the lifespan lies in enhancing knowledge of the poorly understood processes that allow most children to learn to overcome their fear and anxiety but that prevents an important minority from doing so.5 As described below, basic neuroscience research has begun to delineate plasticity-related processes that facilitate minimization or even complete resolution of anxiety states. This research may provide insights on factors that ultimately shape longitudinal anxiety trajectories in humans and thereby may generate novel techniques for facilitating diminution of pediatric anxiety. This, in turn, could impact not only the lives of children but also of the adults that these children become. Research in a range of mammalian species demonstrates striking cross-species conservation in the underlying neural architecture engaged by threats, dangerous stimuli that organisms will extend effort to avoid. Such conservation makes evolutionary sense, in that organisms adept at danger avoidance would be expected to survive. Moreover, individual differences in various mammals also reflect individual differences in functional aspects of this circuit. Key components of this so-called "fear" circuit encompass the amygdala, ventral prefrontal cortex (vPFC), with both medial and lateral expanses, as well as the hippocampus. In terms of clinical translation, two major themes in research on fear-circuitry function focus on plasticity, recognizing two distinct ways in which this circuitry changes in response to changing environmental contingencies as they occur over two vastly different time scales. The first major theme focuses on relatively brief time scales, extending from hours to weeks. This work shows that changes in an organism's response to threat reflect functional, molecular changes in the fear circuit in response to experiences with threats and danger. For example, mammals rapidly learn to fear neutral stimuli that have been paired with dangerous stimuli through a process known as "fear conditioning." This learning-related process is mediated by synaptic changes in lateral amygdala neurons that occur in two phases: an early phase involving protein phosphorylation and a later phase involving protein synthesis, with associated long-term changes in excitatory, glutamatergic cell-signaling properties.5 Thus, intrinsic changes in gulutamate signaling within amygdala neurons supports fear conditioning. On the contrary, extinction learning occurs when a conditioned neutral stimulus is repeatedly presented at later points in time in the absence of any dangerous stimulus. In contrast to fear acquisition, extinction learning involves modulation of lateral amygdala neuron activity through excitatory inputs from the ventral medial prefrontal cortex onto inhibitory intra-amygdala interneurons.5, 6 This modulation does not "erase" or "undo" the changes in amygdala neurons that had occurred during conditioning but rather provides an additional "gate" on their activity. Thus, the development of fear, as occurs during fear conditioning, involves particular forms of plasticity in the basolateral nucleus of the amygdala, whereas a reduction in fear, as occurs in extinction or, perhaps in fear erasure, involves forms of plasticity that evolve in other components of this circuit, including changes in interactions between the amygdala and medial vPFC. As this research reveals the distinct forms of excitatory and inhibitory molecular cascades engaged by such fear-learning experiences, the work provides increasingly precise insights on novel preventative and therapeutic interventions that might target such cascades. The second major theme focuses on longer time scales, which occurs across development. Developmental research on fear in the rodent and nonhuman primate shows that long-term functioning of the adult fear circuit is molded by influences that sculpt functioning in the immature fear-circuit.5 Thus, both environmental and genetic influences on individual differences in fear-circuit function exert both stronger and more persistent effects on individual differences in fear-related behaviors in immature, relative to mature, organisms. Moreover, as with research on fear-circuit plasticity occurring over days-to-weeks, the molecular architecture that enables developmental and even cross-generational shaping of fear-circuit function is being charted with increasing detail. Available work shows that particular molecular cascades are set in motion by particular events that occur in development. For example, elimination of the serotonin 1A receptor, in the serotonin-1A knockout (5HTAR-KO) mouse, produces an anxious phenotype, as does elimination of the serotonin transporter (5HTT).5 Each of these manipulations, however, evolves in a developmental context. Manipulations of the 5HT1AR or the 5HTT only produce these effects on murine anxiety when they occur early in development; the same manipulations in mature mice fails to produce the anxious phenotype seen in adults with early-life genetic manipulations. Similarly, environmental manipulations have been shown to engage related molecular cascades in the rodent. Thus, altering maternal licking and grooming behavior changes expressions of proteins in the hippocampus that inhibit hypothalamic-pituitary-adrenal (HPA) axis response to various stressors.5 Immature rats are more sensitive than mature rats to such persistent molecular changes in the hippocampus; these changes produce long-term alterations in stress-related behavior, through effects on the HPA axis, and these changes are passed on to offspring through changes in molecules that regulate the HPA axis. These effects are thought to have parallels in the human, as reflected in the strong relationship between stress during childhood and both concurrent as well as later anxiety disorders.7 As such, the cascade of effects initiated either by genetic manipulation of 5HT system or environmental manipulations of the HPA axis lead to long-term changes in functioning of the fear circuit. These changes occur specifically when molecular cascades are set in motion during early life as opposed to in maturity. Advances in neuroimaging allow an integration of basic research on fear-circuit plasticity with clinical research on anxiety disorders. Increasingly wide-spread application of functional magnetic resonance imaging (fMRI) technology allows clinical researchers to examine functional changes in the fear circuit with heretofore unseen levels of temporal and spatial resolution. This, in turn, facilitates integration of clinical and basic research by grounding clinical findings in direct measures of fear-circuitry function and plasticity, using measures that are directly translatable across species. The opportunity provided by fMRI to ground clinical research increasingly directly in basic neuroscience theory provides the most immediate opportunity for translational advances, far more immediate than any opportunities for developing any novel diagnostic tests using fMRI, which currently appear far over the horizon. Studies in children and adolescents link individual differences in the fear-circuit to individual differences in clinical anxiety. Three core observations emerge from this work. First, studies show that pediatric anxiety disorders involve enhanced sensitivity in the fear circuit, particularly the amygdala and vPFC.8-10 Second, as with developmental data from longitudinal studies, fMRI studies find signs of both specificity and nonspecificity in the correlates of various psychopathologies. Thus, this work does find signs of specificity: fear-circuit perturbations in pediatric anxiety disorders do not occur in pediatric behavior disorders. For example, pediatric anxiety disorders are characterized by amygdala hyperactivity to fearful facial displays;8 such hyperactivity does not occur in children with some forms of behavior disorders.11 On the other hand, similar forms of fear-circuit dysfunction manifest in youths with anxiety disorders, major depressive disorder, and risk factors for these conditions related to temperament, genetics, or family history.9, 12, 13 Each of these groups, unlike some children with certain behavior disorders, also manifests amygdala hyperactivity to fear faces. Finally, the data suggest that fear-circuit dysfunction relates to perturbations in plasticity. This is because the neural correlates of many anxiety-related states each appear to be heavily context specific; the amygdala response to threats in healthy children, pediatric anxiety disorders, and pediatric major depressive disorder can appear similar when children are cued to attend to some aspects of threats.14, 15 In other contexts, when children are cued to attend to other aspects of threats, both pediatric anxiety and major depressive disorders can appear similarly hypersensitive to threats, whereas in still other contexts, all three groups of children can appear distinct, in terms of their amygdala-based sensitivities.9 Thus, experimental manipulation of the psychological context can either acutely unmask or obscure anxiety-related between-group differences in fear-circuit function. fMRI work reveals fear-circuit dysfunction in pediatric anxiety-related states to represent the failure to adapt appropriately to the varied contexts in which threats are processed, rather than an overall tendency across many contexts to exhibit enhanced fear-circuit activity. As noted above, some of the most clinically relevant insights from basic work on fear emerge from studies of fear-circuit plasticity. Environmental, genetic, and experiential factors that sculpt fear-related behavior are understood with increasing detail. Hence, manipulations of these very same factors in humans may be used to alleviate clinical anxiety states. Moreover, since the effects of such manipulations appear particularly profound on the immature rodent or primate fear-circuit, understanding the most powerful way to reduce fears in the rodent and nonhuman primate may provide particularly important avenues for treating anxious children and adolescents. Nevertheless, the safe and successful translation of such basic findings from rodents or nonhuman primates to clinical studies in humans is predicated on functional cross-species conservation of mechanisms facilitating fear-circuit plasticity. Thus, development of novel paradigms for examining fear-circuit plasticity in humans, particularly children and adolescents, represents a key avenue for translational studies in anxiety disorders. Only through such work can we confirm such cross-species conservation of relevant mechanisms. However, the need for such paradigms creates obvious, unique technical and ethical hurdles, in that research on fear, by its very nature, involves examination of aversive states. Recent advances have laid the groundwork for clearing these hurdles. Methods have been developed for safely and ethically examining aversive states in children and adolescents, albeit using less aversive procedures than typically employed in adults. Moreover, these methods have been used to demonstrate parallels between animal models of pathological anxiety and plasticity-related perturbations in both children and adults. Thus, work with fear conditioning paradigms shows that anxious adults exhibit relatively indiscriminate responses to both overt and ambiguous threats, a sign of perturbed learning, whereas threat responding in healthy adults is more discriminating. In other words, anxious adults do show greater responding than nonanxious adults to overt threats presented, in the context of fear conditioning paradigms; however, anxious adults also show enhanced responses to ambiguous threats.14 Levels of conditioning can, in fact, appear similar in anxious and nonanxious adults, when conditioning is indexed by the differential response to overt, relative to ambiguous threats, since the similar levels of hypersensitivity occur in anxious adults to the two classes of stimuli. Rodent analogues of pathological anxiety in adult humans demonstrate similarly indiscriminant responding to threats, as do children and adolescents with various anxiety states. Figure 1 demonstrates an example of one experimental context where clinical anxiety-related differences in the response to danger have been demonstrated. In this example, children and adolescents are conditioned to one of two neutral faces, using a loud-sound unconditioned stimulus (UCS), paired with a facial photograph manifesting fear, a stimulus to which anxious individuals manifest extreme responses in the fear circuit. Since this paradigm relies on conditioning procedures, a basic form of learning, the paradigm examines aspects of plasticity. As predicted, anxious children and adolescents studied with this paradigm develop greater fear responses than healthy individuals to conditioned fear cues; moreover, as in both clinically anxious adults and animal models of pathological anxiety, these increased responses appear indiscriminately to both conditioned and unconditioned cues.14, 15 Schematic depiction of conditioning-extinction fMRI paradigm. Thus, data in adults suggest that one fundamental deficit in anxiety disorders is a lowering of the threshold for eliciting defensive behavior, due to failure to discriminate appropriately overt as opposed to ambiguous threats. Figure 1 illustrates potential methods for evaluating with precision the ability of anxious youth to exhibit discriminate responding in such circumstances. In this example, a child is first exposed on "Day 1" to a conditioning experience, as described in the preceding paragraph, where only the conditioned stimulus (CS+) but not the unconditioned stimulus (CS−) is paired with the aversive UCS. On "Day 2," the child is exposed to the original CS+, the original CS−, as well as a novel, ambiguous stimulus; the novel computer-generated stimulus shown in the figure on "Day 2" incorporates 50% of features in the CS+ and 50% of features in the CS−; innumerable other ambiguous stimuli can also be generated, parametrically incorporating admixtures of CS+ and CS− features. Available data suggest that a deficit in learning about the boundaries between safe and dangerous stimuli leads the anxious child to elicit a heightened fear-circuit response, in particular contexts, and the precise form of this deficit could be charted using adaptations of the procedure shown in the figure. Such a charting in anxious and healthy children could encourage efforts to hone novel behavioral and pharmacological treatments in animal models that facilitate plasticity in the service of improved learning about discriminations among subtle forms of danger. Acquisition of this information can then be reflected back on the clinic, where these novel techniques might be used to sculp children's abilities to discriminate among subtle forms of danger, in the hope of generating novel treatments or preventative interventions. Novel treatments have been slow to evolve in virtually all areas of mental health science. This reflects the fact that an initial wave of effective treatments had emerged through serendipitous discovery, based in astute clinical observation. In other branches of medicine, initial waves of clinically based discoveries have given rise to new treatments when sound models of normal and abnormal organ-system physiology have emerged. This has not yet happened in mental illnesses. Nevertheless, with anxiety disorders, translational neuroscience has begun to generate promising models. These recognize three essential aspects of anxiety disorders: their firm foundation in development; their link to a dedicated neural architecture; and the role of learning-related plasticity within this architecture in both the rise and fall of anxiety. As these models generate increasingly detailed ideas about novel avenues for treatment and prevention, hope has risen for a coming wave of novel, more effective interventions. Dr. Daniel Pine is currently the Chief of the Section on Development and Affective Neuroscience, Chief, Emotion and Development Branch, and Chief of Child and Adolescent Research in the Mood and Anxiety Disorders Program of the National Institute of Mental Health Intramural Research Program. Dr. Pine moved to this position in the fall of 2000, after 10 years of training, teaching, and research at the Department of Child and Adolescent Psychiatry in the New York State Psychiatric Institute and the College of Physicians and Surgeons of Columbia University. Since graduating from medical school at the University of Chicago, Dr. Pine has been engaged continuously in research focusing on the epidemiology, biology, and treatment of psychiatric disorders in children and adolescents. Currently, his group at the NIMH is examining the degree to which mood and anxiety disorders in children and adolescents are associated with underlying abnormalities in the amygdala, prefrontal cortex, and other brain regions that modulate activity in these structures. Dr. Pine has received Career Development and R01 extramural grant support from the NIMH, a NARSAD Independent Investigator Award, the Joel Elkes Award from the American College of Neuropsychopharmacology for research contributions to psychopharmacology as well as the Blanche Ittelson Award from the American Psychiatric Association for outstanding research contributions to the field of child psychiatry.
Source: Depression and Anxiety
DOI: 10.1002/da.20595
Author: Daniel S. Pine
Language: English
Subfield: Experimental and Cognitive Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W2083955537
